Antioxidant and anti-inflammatory activity of aryl-acetic and hydroxamic acids as novel lipoxygenase inhibitors

Medicinal Chemistry

Volumn 2, Issue 3, 2006, Pages 251-264

  Pontiki, E ^a   Hadjipavlou Litina, D ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Anti inflammatory agents; Antioxidant agents; Aryl acetic; Aryl hydroxamic acids; Lipoxygenase inhibitors

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2 PHENYL 3 THIOPHEN 2 YL ACRYLIC ACID; 3 (3 PHENOXYPHENYL) 2 PHENYLACRYLIC ACID; 3 (3 PHENOXYPHENYL)ACRYLIC ACID; 3 THIOPHEN 2 YL ACRYLIC ACID; 4 METHYL 2,5 DIPHENYLPENTA 2,4 DIENOIC ACID; 4 METHYL 2,5 DIPHENYLPENTA 2,4 DIENOIC ACID HYDROXAMIDE; 4 METHYL 5 PHENYLPENTA 2,4 DIENOIC ACID; 4 METHYL 5 PHENYLPENTA 2,4 DIENOIC ACID HYDROXAMIDE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; ARYLACETIC ACID DERIVATIVE; CARRAGEENAN; DIMETHYL SULFOXIDE; FREE RADICAL; HYDROXAMIC ACID DERIVATIVE; HYDROXYL RADICAL; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; N HYDROXY 2 PHENYL 3 THIOPHEN 2 YL ACRYLAMIDE; N HYDROXY 3 (3 PHENOXYPHENYL) 2 PHENYLACRYLAMIDE; N HYDROXY 3 (3 PHENOXYPHENYL)ACRYLAMIDE; N HYDROXY 3 THIOPHEN 2 YL ACRYLAMIDE; SCAVENGER; SUPEROXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG SYNTHESIS; ENZYME INHIBITION; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LIPID PEROXIDATION; LIPOPHILICITY; PATHOPHYSIOLOGY; PAW EDEMA; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SCAVENGING SYSTEM; THIN LAYER CHROMATOGRAPHY; TISSUE INJURY;

ACETIC ACIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HYDROXAMIC ACIDS; LIPOXYGENASE INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; RATS; RATS, INBRED F344; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33746134377     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340606776930763     Document Type: Article

References (54)

1. Hilbers, P.M.; Rossi, A.; Finazzi-Agro, A.; Veldink, G.A.; and Vliegenthart, F.G.J., Biochim. Biophys. Acta, 1994, 1211, 239.
2. Stallings, C.W.; Kroa, B.A.; Carroll, R.T.; Mertzer, A.L. and Funk, M.O., J. Mol. Biol., 1990, 211, 685.
3. Boyington, J. C. and Amzel, L. M., J. Biol. Chem., 1990, 165, 12771.
4. Veldink, G.A.; Vliegenthart, J.F.G., Adv. Inorg. Biochem., 1984, 6, 139.
5. Nelson, M.J.; Seitz, S.P., Curr. Opin. Struct. Biol. 1994, 4, 878.
6. Solomon, E.I.; Zhou, J.; Neese, F.; Pavel, E.G., Chem. Biol., 1997, 4, 795.
7. DeGroot, J. J. M. C.; Aasa, R.; Malmstrom, B. G.; Slappendel, S.; Veldink, G. A.; Vliegenthart, J. F. G., Biochim. Biophys. Acta, 1975, 377, 71.
8. Gardner, K. A.; Mayer, J. M., Science 1995, 269, 1849.
9. Rickert, K. W.; Klinman, J. P., Biochemistry 1999, 38, 12218.
10. Knapp, M.; Seebeck, F. P.; Klinman, J., J. Am. Chem. Soc. 2001, 123, 2931.
11. Samuelsson, B, Science, 1983, 220, 568.
12. Redkar-Brown, D.G.; Aharony, J., Eur. J. Pharmacol. 1989, 165, 113.
13. Jones, T.R.; Carette, L.; Denis, D., Br. Pharmacology, 1988, 95, 309.
14. Denzlinger, C.; Grimberg, M.; Kapp, A.; Whilmanns, W.; J. Allergy Clin. Immunol., 1990, 85, 218.
15. McMillan, R.M.; Walker, E. R., Trends Pharmacol. Sci., 1992, 13 (8), 323.
16. Young, R.N., Eur. J. Med. Chem., 1999, 34, 671.
17. Julemont, F.; Dogne, J.M.; Laeckmann, D.; Pirotte, B., X. de Leval, Expert Opin. Ther. Patents 2003, 13 (1), 1.
18. Corey, E. J.; Cashmin, J. R.; Kanther, S. S.; Wright, S. W., J. Am. Chem. Soc. 1984, 106, 1503.
19. Kerdesky, F. A. J.; Holms, H. H.; Schmidt, S. P.; Dyer, R. D.; Carter, G. W., Tetrahedron Lett. 1985, 26, 2143.
20. Jackson, W. P.; Islip, P. J.; Kneen, G.; Pugh, A.; Wates, P. J., J. Med. Chem., 1988, 31, 499.
21. Summers J. B.; Gunn B. P.; Martin J. G., Martin M. B.; Mazdiyasni H.; Stewart A. O.; Young P. R.; Bouska J. B.; Goetze A. M.; Dyer R. D.; Brooks D. W.; and Carter G. W.; J. Med. Chem., 1998, 31, 1960.
22. Day, R.O.; Graham, G.G.; Williams, K.M.; Brooks, P.M., Drugs, 1998, 643.
23. Ellis, G.A. and Blake D.R., Ann. Rheum. Dis., 1993, 241.
24. Pontiki E. and Hadjipavlou-Litina D., Arzneim. Forsch./Drug Res., 2003, 53, 780.
25. Summers J. B.; Mazdiyasni Hormoz; Holms J. H.; Ratajczyk J. D.; Dyer R. D.; and Carter G. W.; J. Med. Chem. 1987, 30, 574.
26. Marson, C. M.; Serradji, N.; Rioja, A. S.; Gastaud, S. P.; Alao, J. P.; Coombes, C. and Vigushin, D.M., Biorg. and Med. Chem. Let., 2004, 14, 2477.
27. Biedermann, A.B. 19, 1855.
28. Werbel, L.M., Headen, N. and Eslsager E. F., J. Med. Chem., 1968, 11, 1073.
29. Hansch, C.; Leo, A.J. In: Exploring QSAR Fundamentals and applications in Chemistry and Biology, Heller, S.R. ed. ACS Professional Reference Book, Washington, D.C.; 1995, Chapter 7, I, pp. 279-280.
30. Biobyte Corp., C-QSAR Database 201 West 4th Str., Suite 204, Claremont CA, California 91711, USA.
31. Shen T.Y. In: Burger's Medicinal Chemistry, Non steroidal anti-inflammatory agents, Wolf, M.E., Ed. John Wiley and Sons, New York, 1980, pp. 1217-1219.
32. Winter, C.A. In: Gattini, S and Dukes, M.N.G., eds., Non-steroidal Anti-inflammatory Drugs Excepta Medica, Amsterdam, 1965, p. 190.
33. Kuroda, T.; Suzuki, F.; Tamura, T.; Ohmori, K.; Hosoe, H., J. Med. Chem., 1992, 1130.
34. Taraborewala, R.B. and Kauffman, J.M. J. Pharm. Sci. 1990, 173.
35. Muller, K. Archiv. Phar. 1994, 327, 3.
36. Kemal, C.; Louis-Flamberg, P.; Krupinski-Olsen, R.; Shorter, A.L., Biochemistry 1987, 26, 7064.
37. Van der Zee, J.; Elimg, T.E.; Mason, R.P., Biochemistry 1988, 32, 171.
38. (a) Pontiki E. and Hadjipavlou-Litina, D., Internet Electron. J. Mol. Des. 2002, 1, 134,
39. (b) Pontiki, E. and Hadjipavlou-Litina D., Mini Rev. Med. Chem. 2003, 3, 487.
40. Pontiki, E. and Hadjipavlou-Litina D., Curr. Med. Chem., 2004, 3, 139.
41. Dimmock, J.R.; Kandepu, N.M., Hetherington, M.; Quail, J.W.; Pugazhenthi, U.; Sudom, A.M.; Chamankhah, M.; Rose, P.; Pass, E.; Allen, T.M.; Halleran, S.; Szydlowski, J.; Mutus, B.; Tannous, M., Manavathu, E.K.; Myers, T.G.; Clercq, E.D. and Balzarini, J., J. Med Chem., 1998, 41, 1014.
42. Benvenuto, J. A.; Connor, T. H.; Monteith, D. K.; Laidlaw, J. L.; Adams, S. C.; Matney, T. S.; Theiss, J. C., J. Pharm. Sci., 1993, 82, 988.
43. Rekker R., Hydrophobic Fragmentalt constant, Elsevier Eds., Scintific Co, 1977, 1, 19.
44. Kalsi, R.; Rande, K.; Bhalla, T.N.; Barthwal, J.P.; Parmar, S.S., J. Pharm. Sci., 1990, 79, 317.
45. Chi, S.C.; Won Jun, H., J. Pharm. Sci., 1990, 79, 974.
46. Blois, M.S. Nature (London), 1958, 181, 1199.
47. Nash, T., Biochem. J., 1953, 55, 416.
48. Klein, S. M.; Kohen G.; Gederbraum A. I., Biochemistry, 1981, 20, 6006.
49. Kiichi Ito and Kauro Nakajima, J. Heterocyclic Chem., 1998, 25, 511.
50. Kulmacz R.J.; Lands W.E.M., In Prostaglandins and Related substances: a pratical approach, "Cyclooxygenase: measurement, purification and properties", Benedetto C., McDonald-Gibson R.G., Nigam, S., Slater T.F., Eds., Irl. Press, Oxford (England), 1987, p.209.
51. Jeding, I.; Evans, P.J.; Akanmu, D.; Dexter, D.; Spencer, J.D.; Auroma, O.I.; Jenner P. and Halliwell B., Biochem. Pharm., 1995, 49(3), 359.
52. Evans, J.P.; Cecchini, R.; Halliwell, B., Biochem. Pharmacol., 1992, 44, 981.
53. Candan, F. J. Enz. Inhib. Med. Chem, 2003, 18, 59.
54. Miles, P.R.; Wright, G.R.; Bowman, L. and Colby, H., Biochem. Pharmacol., 1990, 29, 565.